Author Profile

Destiny Hinton

Destiny HInton

Destiny Hinton is a communications intern in the Department of Communications & Scientific and Medical Content Outreach at St. Jude Children’s Research Hospital.

Stories by Destiny Hinton

Clinical

Postural balance is an issue with pediatric leukemia survivors

Mitra Varedi

Think balance is simply staying upright? It’s much more complicated than that, especially if you’re a survivor.

Clinical

Pediatric otolaryngology: Taking care of ears, noses and throats

Elizabeth Jane Walker

Pediatric cancers cause many problems above the neck. Pediatric otolaryngology seeks to repair cancer’s damage to children’s ears, noses and throats.

Outreach

Truly exceptional: Ranking reflects commitment to addressing cancer’s questions

Charles Roberts, MD, PhD

Read what happens when you get scientists and doctors together to help children.

Clinical

For some childhood cancer survivors, new hardships await

I-Chan Huang, PhD

Overcoming childhood cancer is only the beginning of the journey – a whole new set of problems await.

Clinical

Even teens with chronic medical illnesses need to be allowed to be teens

Kendra Parris, PhD

Raising a teen is hard enough without the added stress of a medical condition — here’s nine ways you can help them and foster their development.

Clinical

Occupational therapy: how all work and more play restores some “normal” to childhood

Jessica Sparrow, OTD, OTR L, BCP

Making pizza sounds fun, but it’s a practical example of how we help kids regain the skills to do the activities that are important to them.

Research

The SILver Lining: The yin-yang balance of proteins in muscle disease

Viraj Ichhaporia

Ever heard of Marinesco-Sjögren syndrome? A St. Jude lab found the mutation that causes it.

Clinical

Central line infections: How ETHEL helped us to bust a myth

Josh Wolf, PhD, MBBS

A simple line drawing helped uncover something unexpected about central line infections. Read how it will save lives.

Research

New studies raise warnings with CRISPR-Cas9, but there's more to the story

Shondra Pruett-Miller, PhD

Recent studies highlight efficacy and safety issues of CRISPR. While the results are important, read why we should wait before drawing conclusions.

Research

All in the family: How 59,000 volunteers and a team of scientists helped uncover six inherited gene mutations for medulloblastoma

Paul Northcott, PhD

There were 110 suspect genes. We found the six that could lead to childhood brain tumors.